Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

285
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on JOHNSON & JOHNSON
10:09a JOHNSON & JOHNSON : Janssen Pharmaceuticals, Inc. Completes Divestiture of U.S. ..
10:09a JOHNSON & JOHNSON : New Study Published in JAMA Psychiatry Found Three-Month Pal..
10:09a JOHNSON & JOHNSON : FDA Approves Label Update for ZYTIGA« to Include Statistical..
09:44a JOHNSON & JOHNSON : Reports 2015 First-Quarter Results:
09:44a JOHNSON & JOHNSON : Janssen Announces SVR12 Rates with Twelve Weeks of Treatment..
07:33a JOHNSON & JOHNSON : BRIEF: People in business
04/24 JOHNSON & JOHNSON : to Host Pharmaceutical Business Review
04/23 JOHNSON & JOHNSON : hikes quarterly dividend 7 pct. at annual meeting, cites str..
04/23DJJOHNSON & JOHNSON : Lifts Dividend
04/23DJJOHNSON & JOHNSON : Lifts Dividend
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF